Asthma is a respiratory condition, where
the airways become inflamed and narrow, which can cause a serious and incurable
condition if left untreated. Breathlessness, wheezing and coughing are some of
the symptoms of asthma and it can be controlled by avoiding triggers and with
the help of drug therapy. Environmental triggers may vary from consumer to
consumer but it can include exercise, smoke, cold air and other allergens such
as pollen, dust mites, and infections. The wheezing in asthma begins when the
chemicals present in the lungs overreact to the dust mites, cold air and exercise.
According to Centers for Disease
Control and Prevention (CDC), asthma is an ordinary chronic airway disorder which
is characterized by swelling of air passages that convey air from mouth and
nose to lungs. Asthma is caused generally due to allergies leading to
inflammation of lungs. GlaxoSmithKline Pharmaceuticals Limited and Novartis AG
are developing once-a-day combination products that are longer acting than
currently available drugs and more suitable for patients due to its advantage of
being taken only once a day.
The asthma drugs medications can be categorized
as relievers, such as beta-2 agonists-soothe, and controllers, such as corticosteroids.
On the basis of the treatment type, asthma market can be categorized as bronchodilators,
combination therapies and anti-inflammatories. Bronchodilators can further be
sub-categorized as short acting bronchodilators, anticholinergic,
bronchodilators and long acting bronchodilators. Anti-inflammatories can
further be sub-categorized as anti-leukotrienes, inhaled corticosteroids and monoclonal
antibodies.
Many companies are focusing on
contract manufacturing outsourcing and some of the major healthcare companies
have entered the asthma market in recent years. Increasing awareness about the reimbursement
of timely diagnosis for asthma and accessibility of healthcare utensils for the
diagnosis of asthma in rural areas are some of the major drivers for the global
asthma market. With rising pollution level in urban areas of developing
countries, coupled with strengthening healthcare services in these countries,
the global asthma market is expected to increase in the coming years.
Daily exposure to hazardous working
environment, influx of pollutants in the air, increase in population
susceptible to indoor air pollutants, increase in disposable income, increasing
population of smokers, improved healthcare facility, and growing aging
population are some of other the major factors that are driving the growth of
asthma market. Factors that are restraining the growth of asthma market are high
cost of asthma treatment, patent expiry of many best-seller brands and long
treatment continuation. Additionally, lack of diagnostic tools for
reliable asthma diagnosis in young children is also limiting the growth of
global asthma market.
Country wise, U.S. and China are the two
major markets of asthma. Growth in urbanization and change in lifestyle in
China are the major factor for the increasing asthma in the country. The incidence
of asthma symptoms is higher in urban areas as compared to rural areas due to
factors such as air pollution and smoking, and it has led to the quick increase
in asthma patients in China.
Some of the major competitors of global
asthma market are, CHIESI Farmaceutici S.p.A., Aerovance, Inc., Ono Pharmaceutical
Co., Ltd., GlaxoSmithKline plc, Teva Pharmaceutical Industries Ltd. Merck Sharp
& Dohme Corp.(Merck & Co., Inc.), Sunovion Pharmaceuticals, Inc., Novartis
AG, C.H. Boehringer Sohn AG & Ko., KG, Astellas Pharma Inc., Schering
Corporation, Genentech Inc., and Theravance Inc.
About
P&S Market Research
P&S Market Research is a global
market research and consulting company. We provide market research reports,
industry reports, business intelligence and research based consulting services
across a range of industries.
With the help of our professional
corporate relations with various companies, our market research offers the most
accurate market forecasting. Our analysts and consultants interact with leading
companies of the concerned domain to substantiate every single data presented
in our publication. Our research assists our client in identifying new and
different windows of opportunity and frame informed and customized strategies
for expansion in different regions.
Contact:
Ms Somya
Manager – Client Partner
347, 5th Ave. #1402
New York City, NY - 10016
US/ Canada Toll-Free: 1-888-778-7886
Web: https://www.psmarketresearch.com
No comments:
Post a Comment